Recent Quarter Total Invested
$1.18 B
Recent Quarter Institutional Ownership Percentage
102.44%
Total Invested of Last Quarter
$1.24 B
Ownership Percentage of Last Quarter
112.38%
Arcutis Biotherapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 08/05/2024 | 11.57 M | $107.62 M | -4.97% | 9.37% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2024 | 10.00 M | $93.04 M | 27.00% | 8.10% |
| RUBRIC CAPITAL MANAGEMENT LP | 08/13/2024 | 9.82 M | $91.30 M | 30.71% | 7.95% |
| BLACKROCK INC. | 08/13/2024 | 8.62 M | $80.19 M | 29.49% | 7.76% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/15/2024 | 8.79 M | $81.70 M | 0.00% | 7.11% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 6.88 M | $63.98 M | -0.10% | 5.57% |
| VANGUARD GROUP INC | 08/13/2024 | 6.14 M | $57.14 M | 18.93% | 5.53% |
| STATE STREET CORP | 08/14/2024 | 5.13 M | $47.75 M | -41.54% | 4.62% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 4.44 M | $41.28 M | -4.40% | 3.59% |
| MORGAN STANLEY | 10/17/2024 | 3.97 M | $36.95 M | -0.84% | 3.22% |
| GILDER GAGNON HOWE & CO LLC | 08/14/2024 | 3.62 M | $33.63 M | -14.60% | 2.93% |
| CITADEL ADVISORS LLC | 08/14/2024 | 2.93 M | $27.27 M | 53.20% | 2.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 2.42 M | $22.52 M | 22.82% | 2.18% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 2.53 M | $23.48 M | 18.82% | 2.04% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 2.13 M | $19.84 M | -28.41% | 1.73% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 1.88 M | $17.50 M | 0.50% | 1.69% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2024 | 2.04 M | $18.98 M | 0.65% | 1.65% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2024 | 1.67 M | $15.51 M | -3.10% | 1.35% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 1.56 M | $14.49 M | 107.80% | 1.26% |
| JPMORGAN CHASE & CO | 08/12/2024 | 1.29 M | $11.95 M | 28.48% | 1.16% |
| TEJARA CAPITAL LTD | 08/14/2024 | 1.34 M | $12.50 M | 42.86% | 1.09% |
| J. GOLDMAN & CO LP | 08/14/2024 | 1.31 M | $12.20 M | -8.62% | 1.06% |
| CANDRIAM S.C.A. | 08/05/2024 | 1.31 M | $12.16 M | 100.00% | 1.06% |
| AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 1.23 M | $11.45 M | 18.33% | 1.00% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 1.01 M | $9.37 M | 364.52% | 0.91% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 1.11 M | $10.36 M | 401.11% | 0.90% |
| INVESCO LTD. | 08/13/2024 | 937,594 | $8.72 M | 7.48% | 0.84% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 08/12/2024 | 1.03 M | $9.59 M | -48.76% | 0.83% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 965,392 | $8.98 M | -56.24% | 0.78% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 851,324 | $7.92 M | 13.40% | 0.77% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 807,334 | $7.51 M | 0.10% | 0.73% |
| EVERSEPT PARTNERS, LP | 08/14/2024 | 837,847 | $7.79 M | 100.00% | 0.68% |
| NORTHERN TRUST CORP | 08/14/2024 | 751,850 | $6.99 M | 0.39% | 0.68% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 735,042 | $6.84 M | 196.17% | 0.66% |
| TWO SEAS CAPITAL LP | 08/14/2024 | 762,190 | $7.09 M | -5.82% | 0.62% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 634,441 | $5.90 M | 31.06% | 0.57% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 667,259 | $6.21 M | 83.88% | 0.54% |
| PRUDENTIAL FINANCIAL INC | 08/13/2024 | 572,615 | $5.33 M | -20.84% | 0.52% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 567,123 | $5.27 M | -33.32% | 0.51% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 512,696 | $4.77 M | 35.26% | 0.46% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 563,171 | $5.24 M | -40.31% | 0.46% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 488,600 | $4.54 M | 47.66% | 0.44% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 500,000 | $350,000 | 100.00% | 0.40% |
| IKARIAN CAPITAL, LLC | 08/14/2024 | 489,642 | $4.55 M | -16.96% | 0.40% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 437,362 | $4.07 M | -43.98% | 0.35% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 390,202 | $3.63 M | 25.82% | 0.32% |
| FEDERATED HERMES, INC. | 08/08/2024 | 350,114 | $3.26 M | 0.00% | 0.32% |
| LAZARD ASSET MANAGEMENT LLC | 08/14/2024 | 359,997 | $3.35 M | 100.00% | 0.29% |
| FISHMAN JAY A LTD/MI | 08/05/2024 | 346,600 | $3.22 M | 54.53% | 0.28% |
| UBS GROUP AG | 08/14/2024 | 309,571 | $2.88 M | -36.91% | 0.28% |
Arcutis Biotherapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ARQT shares?
During the previous two years, 196 institutional investors and hedge funds held shares of Arcutis Biotherapeutics, Inc.. The most heavily invested institutionals were:
PRINCIPAL FINANCIAL GROUP INC: 0
RAYMOND JAMES & ASSOCIATES: 0
MATHER GROUP, LLC.: 0
Entropy Technologies, LP: 0
MACROVIEW INVESTMENT MANAGEMENT LLC: 0
JENNISON ASSOCIATES LLC: 11.57 M
-
What percentage of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors?
102.44% of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ARQT ?
Institutional investors have bought a total of 127.21 M shares in the last 24 months. This purchase volume represents approximately $1.19 B in transactions.